Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Styles

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1992
c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodiesM A Bakir, S Eccles, J W Babich, et al.
Journal of Virology|July 26, 2019
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus ChallengeTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.
Antibiotics (Basel, Switzerland)|April 26, 2020
Investigating Bacteriophages Targeting the Opportunistic Pathogen <i>Acinetobacter baumannii</i>Kathryn M Styles, Rapee Thummeepak, Udomluk Leungtongkam, et al.
Frontiers in Immunology|February 4, 2020
Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus InfectionAmudhan Murugesan, Chris Ibegbu, Tiffany M Styles, et al.
Journal of Virology|January 18, 2019
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope VariantsSamantha Burton, Lori M Spicer, Tysheena P Charles, et al.
Nature|February 4, 2021
Molecular basis for control of antibiotic production by a bacterial hormoneShanshan Zhou, Hussain Bhukya, Nicolas Malet, et al.
Frontiers in Immunology|August 1, 2022
Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV CureStella J Berendam, Ashley N Nelson, Bhrugu Yagnik, et al.
Cell Reports|March 2, 2022
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodiesAnusmita Sahoo, Edgar A Hodge, Celia C LaBranche, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2016
High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive MacaquesSunil Kannanganat, Linda S Wyatt, Sailaja Gangadhara, et al.
Plos One|April 7, 2016
Community Attitudes and Practices of Urban Residents Regarding Predation by Pet Cats on Wildlife: An International ComparisonCatherine M Hall, Nigel A Adams, J Stuart Bradley, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1992
c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodiesM A Bakir, S Eccles, J W Babich, et al.
Journal of Virology|July 26, 2019
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus ChallengeTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.
Antibiotics (Basel, Switzerland)|April 26, 2020
Investigating Bacteriophages Targeting the Opportunistic Pathogen <i>Acinetobacter baumannii</i>Kathryn M Styles, Rapee Thummeepak, Udomluk Leungtongkam, et al.
Frontiers in Immunology|February 4, 2020
Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus InfectionAmudhan Murugesan, Chris Ibegbu, Tiffany M Styles, et al.
Journal of Virology|January 18, 2019
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope VariantsSamantha Burton, Lori M Spicer, Tysheena P Charles, et al.
Nature|February 4, 2021
Molecular basis for control of antibiotic production by a bacterial hormoneShanshan Zhou, Hussain Bhukya, Nicolas Malet, et al.
Frontiers in Immunology|August 1, 2022
Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV CureStella J Berendam, Ashley N Nelson, Bhrugu Yagnik, et al.
Cell Reports|March 2, 2022
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodiesAnusmita Sahoo, Edgar A Hodge, Celia C LaBranche, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2016
High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive MacaquesSunil Kannanganat, Linda S Wyatt, Sailaja Gangadhara, et al.
Plos One|April 7, 2016
Community Attitudes and Practices of Urban Residents Regarding Predation by Pet Cats on Wildlife: An International ComparisonCatherine M Hall, Nigel A Adams, J Stuart Bradley, et al.
Pageof 18